NHS FPX 5004 Assessment 4 Self Assessment of Leadership, Collaboration, and Ethics
Self-Assessment of Leadership, Collaboration, and Ethics
It is the responsibility of a leader to keep check and balance on the performance of the organization whether the things need modification or not. A responsible leader always ensures the maintenance of discipline in the organization. Everyone should follow the rules and work together for the success of the organization. A leader provides guidance and support to everyone who needs it in the team. This assessment is about the importance of ethics and collaboration in the workplace, its results, and the self-assessment of the leader’s qualities.
Section: 1 Leadership and Collaboration Qualities Relative to Specific Experience
In 2018, after completing my degree in neurology, I was appointed as a Team Leader in an organization. In that organization, clinical trials were being performed on patients who were experiencing epilepsy. In the workplace, my responsibility as a team leader was to give motivation, support, and guidance to the members of the team. My team members were responsible to make a drug that will be effective in the treatment of patients with epilepsy. My all-team members have a shared vision so that they can achieve the goal of making medication for the patients with full focus. As a team leader, my duty was to communicate and supervise the members who were performing clinical trials. I was responsible for the collaboration between them. The organization wants successful results without any problems. I became more experienced as a team leader while working in the organization. According to the research study, almost 3.5 million people are affected with epilepsy in the US. It is increasing day by day in numbers (Axon et al., 2019)
Leadership Approach Implemented
I chose the HEART approach from the leadership approaches for this project. I used a transformational leadership approach. Along with elements of transformational leadership I used the HEART approach in the following way (Singletary, 2020).
H- (High Vision) My vision was high as my duty was to check the needs of the stakeholders, their collaboration, and how their work is effective for our organization.
E- (Expert) I have knowledge related to neurological sciences; therefore, I assisted the team members in their clinical trials with authentic and relevant research studies. It shows the expertness and experience of the team leader because he is responsible for hiring an enthusiastic and dedicated team who will contribute to the achievement of the goal.
A-(Adaptive) As a team leader, I was adaptive according to the situation. I showed a flexible attitude to members who need guidance regarding the execution of trials. The flexibility of the team leader is the reason for the high morale of the team and they tentatively listen to the demand of the team leader.
R- (Responsibility) After completely comprehending my duties, I assigned different tasks to every member of the team. It shows the responsibility of the team leader toward the team members, organization, stakeholders, and doctors who are performing the clinical trials. It shows the dedication of the team leader and ensures that everything has been completed on time.
T- (Team Player) I was available for every team member who need my support at any time and also assisted them in their responsibilities. It is good for the team leader to be a team player. The team leader should have effective communication skills to maintain the workflow in the organization.
NHS FPX 5004 Assessment 4 Self Assessment of Leadership, Collaboration, and Ethics
In my healthcare setting, I used the Heart approach. My vision was high because I encourage everyone on my team to improve their skills for the achievement of the goal. I was approachable and fair to everyone. I had the experience of four years. In my previous job, I also worked as a team leader so I choose those people who were capable and enthusiastic to work on the goal. I was adaptive according to the situation because every time being cold to team members can bring a communication gap. So, I listened to them often. I was dedicated and did hard work for my organization so that everything can be completed smoothly. I was a team player as most often I did not behave like a leader. I make my team members feel that I am one of them and they can easily communicate with me.
My decision-making style was conceptual as I was creative and comfortable with the questions of the team. I enjoyed listening to the new ideas and applying them. I was conscious that my decisions will not affect someone in a bad way.
All the results of the clinical trials depend on leadership. If the leader makes better decisions, then the results would be awesome. I communicated with the patients to see if they have any concerns about the procedure of the clinical trials. I communicated with the doctors too to eliminate the concerns of the patient so that they would feel easy and comfortable while performing the process. The outcome was great because the doctor succeeded to make the drug lamotrigine for patients who experienced epilepsy.
Besides the results, it was crucial to see the process of clinical trials. The Heart model helped me to find sponsors and stakeholders. With the help of stakeholders and sponsors, we were able to get many funds, and support for our project. It helped our project to proceed quickly and the performance was not affected in the clinical trials (Boaz et al., 2018).
The team leaders must be strict because the team members perform well when the leader is serious about the achievement of the goal. There can be conflict among the team members but it is the responsibility of the team members to resolve the conflict for the sake of better results because any fight among the team members or not being on the one page can create problems in the achievement of the goal. There was once conflict among my team members because of different opinions but I resolved it by communicating to them that they are responsible for the safety and care of patients so they should keep their matters aside. I was always there for my team to provide my vision and moral support. Communication is the key to solving any problem in the organization.
I communicated my thoughts with the team members that what type of drug should be made for patients with epilepsy. They all shared their opinions with me and in this way, we came on a final medication that we needed for the safety of the patients (Stern et al., 2020). My aim was to assist the stakeholders if they face any problem. To make sure and complete this criterion, I conducted several meetings with them to let them know that any problem will be solved quickly for the efficiency of the result. The major goal was the formation of the drug and for this, I made teams of neurologists, pharmacists, stakeholders, patients, and nurses (Bunger & Lengnick-Hall, 2018)
My team was happy with me because I always provided them with enough support. To make them motivated, I always praised them for their dedication, hard work, and clear vision of the goal. I openly communicated with them to let them know about my expectations regarding the work. I treated them very kindly so they feel ownership of the goal. It will eventually help us in the achievement of the goal. More than individual work, I rooted for teamwork because in this way we can quickly work on the goal. All these things helped me in getting experience that how to manage a team and how to work with them (Cornett & Kuziemsky, 2018).
Section II: Ethical Dilemma and Action
The formation of the drug and management of the clinical trials demands dedication, hard work, and high energy because mostly the patients or participants have ethical concerns about any procedure of the clinical trials and they want to avoid it for the sake of ethics. It is the right of a participant to know about every procedure being conducted on them and the results of the clinical trials. The patients must be informed about the process of clinical trials and how they are not risky (Clark et al., 2019).
The first ethical dilemma was the usage of a placebo. The risk was there for the use of a placebo because the doctors were not completely sure whether this method for the patients is right or not. Different kinds of strategies were made to cater to the matter so it can eliminate the concerns of the patients (Castelnuovo et al., 2018).
The second ethical dilemma which concerns the patient most is consent forms of information. The participants needed to know which procedure is involved in the clinical trials, does it have any concern or not, and which type of documents the organization demands them to sign. With the help of consent information, they can get information about every treatment and if it goes against their ethics, culture, or religion, they can refuse it (autonomy). I was authorized to take action against team members who did not follow the code of ethics related to autonomy, beneficence, and non-malice. According to the autonomy, code of ethics, I was very respectful toward the rights of patients. I inform them about a single thing and a few of them had reservations about the consent form so they did not sign it. I respect their decision and the trial was not conducted on them. The consent forms of the WHO (World Health Organization) were used in the process (Solomon et al., 2021). Doctors or nurses who have good clinical practices can promote good ethics. They can make sure the safety of patients ethically. In the healthcare system, ethics should be prioritized over anything.
NHS FPX 5004 Assessment 4 Self Assessment of Leadership, Collaboration, and Ethics
The code of ethics which I used was the Healthcare Executive’s Responsibilities to Patients or Others Served. I try to connect with all the patients and build trust with them. I make sure that every patient must know their healthcare rights, opportunities, and risks related to the healthcare system. I tried to resolve every conflict in my team with the help of communication. I apply these principles when the clinical trials were being performed (American College of Healthcare Executives, n.d.)
Every organization has its main code of ethics for its employees and my organization has ethics of honesty, truth, and professionalism. It was the duty of every employee of the organization to fulfill these ethics so the reputation of the organization can be increased. In the team, once there were two individuals from Korea and one doctor from the United States. They had a conflict at one point during the formation of the drug where my senior manager favored the American doctor. Although the Koreans were right, they had to face problems because of their ethnicity. I talked with the authorities of the organization and they immediately fired the senior manager because he violated the ethics rules. It is the right of everyone to be treated with justice and honesty.
Conclusion
Every organization needs a responsible leader to maintain discipline and to make sure that their customers, like patients in the healthcare system, are not facing problems. Communication is necessary to hear everyone’s point of view. A team leader should be strict to make sure that everyone is working in the right direction. For the achievement of any goal, the leader should be active and hardworking.
References
American College of Healthcare Executives. (2021, December 6). ACHE Code of Ethics. Ache.org. https://www.ache.org/about-ache/our-story/our-commitments/ethics/ache-code-of-ethics
Axon, D. R., Taylor, A. M., Vo, D., & Bingham, J. (2019). Initial assessment of an interprofessional team-delivered telehealth program for patients with epilepsy. Epilepsy Research, 158, 106235. https://doi.org/10.1016/j.eplepsyres.2019.106235
Boaz, A., Hanney, S., Borst, R., O’Shea, A., & Kok, M. (2018). How to engage stakeholders in research: design principles to support improvement. Health Research Policy and Systems, 16(1). https://doi.org/10.1186/s12961-018-0337-6
Bunger, A. C., & Lengnick-Hall, R. (2018). Do learning collaboratives strengthen communication? A comparison of organizational team communication networks over time. Health Care Management Review, 43(1), 50–60. https://doi.org/10.1097/hmr.0000000000000120
Castelnuovo, G., Giusti, E. M., Manzoni, G. M., Saviola, D., Gabrielli, S., Lacerenza, M., Pietrabissa, G., Cattivelli, R., Spatola, C. A. M., Rossi, A., Varallo, G., Novelli, M., Villa, V., Luzzati, F., Cottini, A., Lai, C., Volpato, E., Cavalera, C., Pagnini, F., & Tesio, V. (2018). What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation. Frontiers in Neurology, 9. https://doi.org/10.3389/fneur.2018.00310
Clark, L. T., Watkins, L., Piña, I. L., Elmer, M., Akinboboye, O., Gorham, M., Jamerson, B., McCullough, C., Pierre, C., Polis, A. B., Puckrein, G., & Regnante, J. M. (2019). Increasing diversity in clinical trials: Overcoming critical barriers. Current Problems in Cardiology, 44(5), 148–172. https://doi.org/10.1016/j.cpcardiol.2018.11.002
Cornett, J. A., & Kuziemsky, C. (2018). Team-based communication and the healthcare communication space. Journal of Health Organization and Management, 32(6), 825–840. https://doi.org/10.1108/jhom-07-2017-0189
Singletary, J. (2020). Head, heart, and hand. Social Work & Christianity, 47(4), 3–18. https://doi.org/10.34043/swc.v47i3.126
Solomon, E. D., Mozersky, J., Baldwin, K., Wroblewski, M. P., Parsons, M. V., Goodman, M., & DuBois, J. M. (2021). Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study. Journal of Clinical and Translational Science, 5(1). https://doi.org/10.1017/cts.2021.807
Stern, G., Horn, H., DeFrancesco, J., Ruiz, J., Linton, J., Marchant, M., & Smith, D. (2020). Roundtable discussion: supporting medical devices during unprecedented challenges. Biomedical Instrumentation & Technology, 54(3), 202–208. https://doi.org/10.2345/0899-8205-54.3.202
